Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The home page, the product pages and the disclaimer refer only to a US 503A pharmacy and to compounding pharmacies in general. 2 more criteria also fail; see the table below.
At a glance
MANÜ TelehealthTelehealth service
5/8criteria passed
Price
Semaglutide from $199, tirzepatide from $297
Sells
compounded semaglutide, compounded tirzepatide, and 2 more
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A telehealth service in English and Spanish selling compounded semaglutide and tirzepatide on starter and full dose plans, with a lipotropic injection add-on and a supplement store. Care starts with an online assessment, and no pharmacy is named.
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSLicensed providers review each online assessment and a board-certified provider prescribes only if the patient is approved, and the about page lists the nurse practitioners on the medical team.Source: MANÜ Telehealth's website; MANÜ Telehealth's about page; MANÜ Telehealth's semaglutide page.
S2PASSThe home and product pages list an online assessment of health goals and medical history as the first step, reviewed by licensed providers before any prescription, and no page describes a payment step before it.Source: MANÜ Telehealth's website; MANÜ Telehealth's semaglutide page.
S3FAILNo filling pharmacy is named. The home page, the product pages and the disclaimer refer only to a US 503A pharmacy and to compounding pharmacies in general.Source: MANÜ Telehealth's website; MANÜ Telehealth's tirzepatide page.
S4PASSThe home page and each product page state that the FDA has not evaluated the compounded GLP-1s for safety, quality or efficacy, and the product answers say compounded medications are not FDA-approved.Source: MANÜ Telehealth's website; MANÜ Telehealth's semaglutide page; MANÜ Telehealth's tirzepatide page.
S5FAILNo certificate of analysis or lot document is published on the home page, the product pages or the terms.Source: MANÜ Telehealth's website; MANÜ Telehealth's semaglutide page; MANÜ Telehealth's terms of service page.
S6FAILThe terms name Ziggy Telehealth LLC, but their contact block gives only an email address and a telephone number, and no postal address appears in the footer or the privacy policy; the footer gives the location only as the United States. The terms name Florida law.Source: MANÜ Telehealth's terms of service page; MANÜ Telehealth's privacy policy; MANÜ Telehealth's website.
S7PASSCompounded semaglutide from $199 on the starter plan and from $299 on the full dose plan, and compounded tirzepatide from $297 and from $397. MIC Ultraburn is sold only as an add-on, from $149. The home page instead says GLP-1s cost from $5 a day. Each package includes the consultation, medication, supplies and shipping.Source: MANÜ Telehealth's semaglutide page; MANÜ Telehealth's tirzepatide page; MANÜ Telehealth's MIC ultraburn page; MANÜ Telehealth's website.
S8PASSNo FDA warning letter names MANÜ Telehealth or Ziggy Telehealth LLC, and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, MIC Ultraburn (lipotropic add-on), nutritional supplements.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.